MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the close of its seed financing. Financial details are not disclosed.

MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease. 



www.mitorxtherapeutics.com

Therapeutics

Mitorx Therapeutics Announces Seed Financing To Advance Its Mitochondrial-Protective Therapeutics To Treat Degenerative Diseases

Description

Company Information

Related People

Mitorx Therapeutics Announces Seed Financing To Advance Its Mitochondrial-Protective Therapeutics To Treat Degenerative Diseases

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information